Phase 1 Pharmacokinetics, Safety, and Tolerability Study

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 8, 2019

Primary Completion Date

December 3, 2019

Study Completion Date

February 10, 2020

Conditions

Pain

Interventions

DRUG

XG005

XG005 Tablet

DRUG

Placebos

Placebo Tablet

Trial Locations (1)

Linear Clinical Research Ltd, Nedlands

All Listed Sponsors

lead

Xgene Pharmaceutical Group

INDUSTRY

NCT04067947 - Phase 1 Pharmacokinetics, Safety, and Tolerability Study | Biotech Hunter | Biotech Hunter